The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes

DeFronzo, 1988, Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM., Diabetes, 37, 667, 10.2337/diab.37.6.667

Kahn, 1994, Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes., Diabetes, 43, 1066, 10.2337/diab.43.8.1066

Porte Jr, 1991, Banting lecture 1990. β-cells in type II diabetes mellitus., Diabetes, 40, 166, 10.2337/diabetes.40.2.166

Weyer, 1999, The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus., J Clin Invest, 104, 787, 10.1172/JCI7231

Ludvik, 1997, Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus., J Clin Invest, 100, 2354, 10.1172/JCI119775

DeFronzo, 1985, Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus., J Clin Invest, 76, 149, 10.1172/JCI111938

Shulman, 2000, Cellular mechanisms of insulin resistance., J Clin Invest, 106, 171, 10.1172/JCI10583

Baron, 1991, Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy., J Clin Invest, 87, 1186, 10.1172/JCI115117

Reaven, 1991, Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models., Diabetes Care, 14, 195, 10.2337/diacare.14.3.195

Martin, 1992, Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study., Lancet, 340, 925, 10.1016/0140-6736(92)92814-V

Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism., Nature, 414, 799, 10.1038/414799a

Virkamaki, 1999, Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance., J Clin Invest, 103, 931, 10.1172/JCI6609

Kahn, 1993, Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function., Diabetes, 42, 1663, 10.2337/diab.42.11.1663

Poitout, 2002, Minireview: secondary β-cell failure in type 2 diabetes–a convergence of glucotoxicity and lipotoxicity., Endocrinology, 143, 339, 10.1210/endo.143.2.8623

Bernard-Kargar, 2001, Endocrine pancreas plasticity under physiological and pathological conditions, Diabetes, 50, S30, 10.2337/diabetes.50.2007.S30

Leibiger, 1998, Short-term regulation of insulin gene transcription by glucose., Proc Natl Acad Sci USA, 95, 9307, 10.1073/pnas.95.16.9307

Matschinsky, 1996, Banting lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm., Diabetes, 45, 223, 10.2337/diab.45.2.223

Kulkarni, 1999, Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes., Cell, 96, 329, 10.1016/S0092-8674(00)80546-2

Leibiger, 2001, Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells., Mol Cell, 7, 559, 10.1016/S1097-2765(01)00203-9

Cherrington, 1978, Relationship between the plasma glucose level and glucose uptake in the conscious dog., Metabolism, 27, 787, 10.1016/0026-0495(78)90213-5

Bergman, 1989, Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach., Diabetes, 38, 1512, 10.2337/diab.38.12.1512

Ader, 1997, Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components., J Clin Invest, 99, 1187, 10.1172/JCI119275

Del Prato, 1995, Basal plasma insulin levels exert a qualitative but not quantitative effect on glucose-mediated glucose uptake, Am J Physiol, 268, E1089

Itani, 2003, Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase., Diabetes, 52, 1635, 10.2337/diabetes.52.7.1635

Kahn, 1994, The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects., Diabetes, 43, 587, 10.2337/diab.43.4.587

Ader, 1985, Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements., Diabetes, 34, 1092, 10.2337/diab.34.11.1092

Del Prato, 1997, Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance., Diabetologia, 40, 687, 10.1007/s001250050735

Quon, 1994, Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis., Diabetes, 43, 890, 10.2337/diab.43.7.890

Finegood, 1996, Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method, Am J Physiol, 271, E485

Basu, 1997, Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol., Diabetes, 46, 421, 10.2337/diab.46.3.421

Reaven, 1995, Pathophysiology of insulin resistance in human disease., Physiol Rev, 75, 473, 10.1152/physrev.1995.75.3.473

Unger, 2003, Lipid overload and overflow: metabolic trauma and the metabolic syndrome., Trends Endocrinol Metab, 14, 398, 10.1016/j.tem.2003.09.008

Unger, 2003, Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome., Endocrinology, 144, 5159, 10.1210/en.2003-0870

Bell, 1993, Structure and function of mammalian facilitative sugar transporters., J Biol Chem, 268, 19161, 10.1016/S0021-9258(19)36489-0

Joost, 2002, Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators, Am J Physiol Endocrinol Metab, 282, E974, 10.1152/ajpendo.00407.2001

Barnes, 2002, Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK)., J Cell Sci, 115, 2433, 10.1242/jcs.115.11.2433

Hwang, 2001, Stimulation of GLUT-1 glucose transporter expression in response to hyperosmolarity, Am J Physiol Cell Physiol, 281, C1365, 10.1152/ajpcell.2001.281.4.C1365

Clarke, 1994, Inhibition of the translocation of GLUT1 and GLUT4 in 3T3–L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin, Biochem J, 300, 631, 10.1042/bj3000631

Shi, 1995, Modulation of GLUT1 intrinsic activity in clone 9 cells by inhibition of oxidative phosphorylation., J Biol Chem, 270, 21772, 10.1074/jbc.270.37.21772

Seidner, 1998, GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier., Nat Genet, 18, 188, 10.1038/ng0298-188

Heijnen, 1997, Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from α-granules to the cell surface., J Cell Biol, 138, 323, 10.1083/jcb.138.2.323

Reagan, 1999, Regulation of GLUT-3 glucose transporter in the hippocampus of diabetic rats subjected to stress, Am J Physiol, 276, E879

Jhun, 1992, Effects of insulin on steady state kinetics of GLUT4 subcellular distribution in rat adipocytes. Evidence of constitutive GLUT4 recycling., J Biol Chem, 267, 17710, 10.1016/S0021-9258(19)37100-5

Rodnick, 1992, Interaction of insulin and exercise on glucose transport in muscle., Diabetes Care, 15, 1679, 10.2337/diacare.15.11.1679

Leturque, 1996, Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle., Diabetes, 45, 23, 10.2337/diab.45.1.23

Tsao, 1996, Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle., Diabetes, 45, 28, 10.2337/diab.45.1.28

Shepherd, 1993, Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue., J Biol Chem, 268, 22243, 10.1016/S0021-9258(18)41516-5

Zisman, 2000, Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance., Nat Med, 6, 924, 10.1038/78693

Katz, 1995, Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4., Nature, 377, 151, 10.1038/377151a0

Stenbit, 1996, Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle., J Clin Invest, 98, 629, 10.1172/JCI118833

Hogan, 1991, Glucose transporter gene expression in early mouse embryos., Development, 113, 363, 10.1242/dev.113.1.363

Levitsky, 1994, GLUT-1 and GLUT-2 mRNA, protein, and glucose transporter activity in cultured fetal and adult hepatocytes, Am J Physiol, 267, E88

Noel, 1997, Structural domains that contribute to substrate specificity in facilitated glucose transporters are distinct from those involved in kinetic function: studies with GLUT-1/GLUT-2 chimeras., Biochemistry, 36, 5465, 10.1021/bi9630624

Tiedge, 1991, Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic β-cells, Biochem J, 279, 899, 10.1042/bj2790899

Tal, 1992, Expression and function of GLUT-1 and GLUT-2 glucose transporter isoforms in cells of cultured rat pancreatic islets., J Biol Chem, 267, 17241, 10.1016/S0021-9258(18)41918-7

Burcelin, 1992, Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats, Biochem J, 288, 675, 10.1042/bj2880675

Guillam, 1997, Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2., Nat Genet, 17, 327, 10.1038/ng1197-327

Santer, 1997, Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome., Nat Genet, 17, 324, 10.1038/ng1197-324

Santer, 2002, The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome., Hum Genet, 110, 21, 10.1007/s00439-001-0638-6

Efrat, 1994, The pancreatic β-cell glucose sensor., Trends Biochem Sci, 19, 535, 10.1016/0968-0004(94)90056-6

Porzio, 1999, GLUT2 and glucokinase expression is coordinately regulated by sulfonylurea., Mol Cell Endocrinol, 153, 155, 10.1016/S0303-7207(99)00073-8

Orci, 1990, Evidence that down-regulation of β-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia., Proc Natl Acad Sci USA, 87, 9953, 10.1073/pnas.87.24.9953

Doege, 2001, Characterization of human glucose transporter (GLUT) 11 (encoded by SLC2A11), a novel sugar-transport facilitator specifically expressed in heart and skeletal muscle., Biochem J, 359, 443, 10.1042/bj3590443

Lisinski, 2001, Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells., Biochem J, 358, 517, 10.1042/bj3580517

Ibberson, 2000, GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues., J Biol Chem, 275, 4607, 10.1074/jbc.275.7.4607

Dawson, 2001, Sequence and functional analysis of GLUT10: a glucose transporter in the type 2 diabetes-linked region of chromosome 20q12–13.1., Mol Genet Metab, 74, 186, 10.1006/mgme.2001.3212

Rogers, 2002, Identification of a novel glucose transporter-like protein-GLUT-12, Am J Physiol Endocrinol Metab, 282, E733, 10.1152/ajpendo.2002.282.3.E733

Wright, 2001, Renal Na(+)-glucose cotransporters, Am J Physiol Renal Physiol, 280, F10, 10.1152/ajprenal.2001.280.1.F10

Martin, 1996, Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption., Nat Genet, 12, 216, 10.1038/ng0296-216

Vestri, 2001, Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat., J Membr Biol, 182, 105, 10.1007/s00232-001-0036-y

van den Heuvel, 2002, Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2)., Hum Genet, 111, 544, 10.1007/s00439-002-0820-5

Fink, 1992, Evidence that glucose transport is rate-limiting for in vivo glucose uptake., Metabolism, 41, 897, 10.1016/0026-0495(92)90174-9

Yki-Jarvinen, 1987, Kinetics of glucose disposal in whole body and across the forearm in man., J Clin Invest, 79, 1713, 10.1172/JCI113011

Yki-Jarvinen, 1992, Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients., J Clin Endocrinol Metab, 75, 795

Butler, 1990, Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation., Diabetes, 39, 1373, 10.2337/diab.39.11.1373

Cline, 1999, Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes., N Engl J Med, 341, 240, 10.1056/NEJM199907223410404

Rothman, 1995, Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus., Proc Natl Acad Sci USA, 92, 983, 10.1073/pnas.92.4.983

Zierath, 1996, Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM., Diabetologia, 39, 1180, 10.1007/BF02658504

Garvey, 1998, Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance., J Clin Invest, 101, 2377, 10.1172/JCI1557

Pedersen, 1990, Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM., Diabetes, 39, 865, 10.2337/diab.39.7.865

Maianu, 2001, Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking., J Clin Endocrinol Metab, 86, 5450, 10.1210/jcem.86.11.8053

Garvey, 1991, Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity., J Clin Invest, 87, 1072, 10.1172/JCI115068

Buse, 1992, Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation., Diabetes, 41, 1436, 10.2337/diab.41.11.1436

Goodyear, 1998, Exercise, glucose transport, and insulin sensitivity., Annu Rev Med, 49, 235, 10.1146/annurev.med.49.1.235

Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin., N Engl J Med, 346, 393, 10.1056/NEJMoa012512

Vranic, 1979, Exercise and diabetes mellitus., Diabetes, 28, 147, 10.2337/diab.28.2.147

McVie-Wylie, 2001, Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility., Genomics, 72, 113, 10.1006/geno.2000.6457

Cha, 2002, Analysis of polymorphism of the GLUT2 promoter in NIDDM patients and its functional consequence to the promoter activity., Ann Clin Lab Sci, 32, 114

Muller, 1993, The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro., Diabetes, 42, 1852, 10.2337/diab.42.12.1852

Tsiani, 1995, Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide., Endocrinology, 136, 2505, 10.1210/endo.136.6.7750472

Matthaei, 1991, Association of metformin’s effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes., Diabetes, 40, 850, 10.2337/diab.40.7.850

Galuska, 1994, Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM., Diabetologia, 37, 826, 10.1007/BF00404340

Hallsten, 2002, Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes., Diabetes, 51, 3479, 10.2337/diabetes.51.12.3479

Zhou, 2001, Role of AMP-activated protein kinase in mechanism of metformin action., J Clin Invest, 108, 1167, 10.1172/JCI13505

Mayerson, 2002, The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes., Diabetes, 51, 797, 10.2337/diabetes.51.3.797

Park, 1998, Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-γ., J Clin Endocrinol Metab, 83, 2830

Asano, 2000, Troglitazone enhances glycolysis and improves intracellular glucose metabolism in rat mesangial cells., Metabolism, 49, 308, 10.1016/S0026-0495(00)90088-X

Yonemitsu, 2001, Troglitazone induces GLUT4 translocation in L6 myotubes., Diabetes, 50, 1093, 10.2337/diabetes.50.5.1093

Fryer, 2002, The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways., J Biol Chem, 277, 25226, 10.1074/jbc.M202489200

Inzucchi, 1998, Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus., N Engl J Med, 338, 867, 10.1056/NEJM199803263381303

Petersen, 2000, Mechanism of troglitazone action in type 2 diabetes., Diabetes, 49, 827, 10.2337/diabetes.49.5.827

Cardenas, 1998, Evolution and regulatory role of the hexokinases., Biochim Biophys Acta, 1401, 242, 10.1016/S0167-4889(97)00150-X

Coerver, 1998, Developmental expression of hexokinase 1 and 3 in rats., Histochem Cell Biol, 109, 75, 10.1007/s004180050204

Ehsani-Zonouz, 2001, Interaction of hexokinase with the outer mitochondrial membrane and a hydrophobic matrix., Mol Cell Biochem, 223, 81, 10.1023/A:1017952827675

Liu, 1999, Dual mechanisms for glucose 6-phosphate inhibition of human brain hexokinase., J Biol Chem, 274, 31155, 10.1074/jbc.274.44.31155

Arora, 1993, Structure/function relationships in hexokinase. Site-directed mutational analyses and characterization of overexpressed fragments implicate different functions for the N- and C-terminal halves of the enzyme., J Biol Chem, 268, 18259, 10.1016/S0021-9258(17)46838-4

Printz, 1993, Hexokinase II mRNA and gene structure, regulation by insulin, and evolution., J Biol Chem, 268, 5209, 10.1016/S0021-9258(18)53521-3

Chang, 1996, Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake., J Biol Chem, 271, 14834, 10.1074/jbc.271.25.14834

Ritov, 2001, Hexokinase isozyme distribution in human skeletal muscle., Diabetes, 50, 1253, 10.2337/diabetes.50.6.1253

Koval, 1998, Regulation of hexokinase II activity and expression in human muscle by moderate exercise, Am J Physiol, 274, E304

Jones, 1997, Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine, Am J Physiol, 273, E682

Vogt, 2000, Regulation of hexokinase II expression in human skeletal muscle in vivo., Metabolism, 49, 814, 10.1053/meta.2000.6245

Osawa, 1996, Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin., J Biol Chem, 271, 16690, 10.1074/jbc.271.28.16690

Robey, 2002, Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-activated protein kinase pathway activation and induction of hexokinase II expression., J Biol Chem, 277, 14370, 10.1074/jbc.M111722200

Heikkinen, 1999, Hexokinase II-deficient mice. Prenatal death of homozygotes without disturbances in glucose tolerance in heterozygotes., J Biol Chem, 274, 22517, 10.1074/jbc.274.32.22517

Halseth, 1999, Overexpression of hexokinase II increases insulin and exercise-stimulated muscle glucose uptake in vivo, Am J Physiol, 276, E70

Preller, 1992, Localization of the type III isozyme of hexokinase at the nuclear periphery., Arch Biochem Biophys, 294, 482, 10.1016/0003-9861(92)90715-9

Matschinsky, 1998, Pancreatic β-cell glucokinase: closing the gap between theoretical concepts and experimental realities., Diabetes, 47, 307, 10.2337/diabetes.47.3.307

Bedoya, 1986, Differential regulation of glucokinase activity in pancreatic islets and liver of the rat., J Biol Chem, 261, 10760, 10.1016/S0021-9258(18)67451-4

Magnuson, 1990, Glucokinase gene structure. Functional implications of molecular genetic studies., Diabetes, 39, 523, 10.2337/diab.39.5.523

Brown, 1997, Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus., Diabetes, 46, 179, 10.2337/diab.46.2.179

Postic, 1999, Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase., J Biol Chem, 274, 305, 10.1074/jbc.274.1.305

Christ, 1986, Antagonistic regulation of the glucose/glucose 6-phosphate cycle by insulin and glucagon in cultured hepatocytes., Biochem J, 238, 185, 10.1042/bj2380185

Lange, 1994, Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP., Biochem Biophys Res Commun, 201, 302, 10.1006/bbrc.1994.1702

Chou, 2001, The molecular basis of type 1 glycogen storage diseases., Curr Mol Med, 1, 25, 10.2174/1566524013364112

Trinh, 1998, Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats., J Biol Chem, 273, 31615, 10.1074/jbc.273.47.31615

Iizuka, 2000, Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic β-cell line., J Endocrinol, 164, 307, 10.1677/joe.0.1640307

Vestergaard, 1995, Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients., J Clin Invest, 96, 2639, 10.1172/JCI118329

Ducluzeau, 2001, Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes., Diabetes, 50, 1134, 10.2337/diabetes.50.5.1134

Pendergrass, 1998, Insulin-induced hexokinase II expression is reduced in obesity and NIDDM., Diabetes, 47, 387, 10.2337/diabetes.47.3.387

Laakso, 1995, Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance., Diabetologia, 38, 617, 10.1007/BF00400733

Ardehali, 1996, A novel (TA)n polymorphism in the hexokinase II gene: application to noninsulin-dependent diabetes mellitus in the Pima Indians., Hum Genet, 97, 482, 10.1007/BF02267071

Froguel, 1993, Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus., N Engl J Med, 328, 697, 10.1056/NEJM199303113281005

Froguel, 1992, Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus., Nature, 356, 162, 10.1038/356162a0

Hattersley, 1992, Linkage of type 2 diabetes to the glucokinase gene., Lancet, 339, 1307, 10.1016/0140-6736(92)91958-B

Caro, 1995, Liver glucokinase: decreased activity in patients with type II diabetes., Horm Metab Res, 27, 19, 10.1055/s-2007-979899

Basu, 2000, Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity., Diabetes, 49, 272, 10.2337/diabetes.49.2.272

Glaser, 1998, Familial hyperinsulinism caused by an activating glucokinase mutation., N Engl J Med, 338, 226, 10.1056/NEJM199801223380404

Christesen, 2002, The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy., Diabetes, 51, 1240, 10.2337/diabetes.51.4.1240

Vionnet, 1997, Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs., Diabetes, 46, 1062, 10.2337/diab.46.6.1062

Grimsby, 2003, Allosteric activators of glucokinase: potential role in diabetes therapy., Science, 301, 370, 10.1126/science.1084073

Mevorach, 1998, Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus., J Clin Invest, 102, 744, 10.1172/JCI2720

Clore, 2000, Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes., Diabetes, 49, 969, 10.2337/diabetes.49.6.969

Mithieux, 2002, Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet., Diabetes, 51, 139, 10.2337/diabetes.51.1.139

Chakrabarti, 2002, PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes., Diabetes Obes Metab, 4, 319, 10.1046/j.1463-1326.2002.00218.x

Davies, 1999, Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism., Biochim Biophys Acta, 1451, 122, 10.1016/S0167-4889(99)00080-4

Randle, 1994, Mechanisms modifying glucose oxidation in diabetes mellitus, Diabetologia, 37, S155, 10.1007/BF00400839

Sugden, 2000, Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression, Biochem J, 346, 651, 10.1042/bj3460651

Sugden, 2001, Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-α: implications for glucose-stimulated insulin secretion., Diabetes, 50, 2729, 10.2337/diabetes.50.12.2729

Wu, 2000, Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues., Arch Biochem Biophys, 381, 1, 10.1006/abbi.2000.1946

Coleman, 1991, Genetic regulation of malic enzyme activity in the mouse., J Biol Chem, 266, 21997, 10.1016/S0021-9258(18)54736-0

Nakai, 2002, Exercise training increases the activity of pyruvate dehydrogenase complex in skeletal muscle of diabetic rats., Endocr J, 49, 547, 10.1507/endocrj.49.547

Mostert, 1999, Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring., J Endocrinol Invest, 22, 519, 10.1007/BF03343603

Wilson, 1995, Hexokinases., Rev Physiol Biochem Pharmacol, 126, 65, 10.1007/BFb0049776

Wilson, 2003, Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function., J Exp Biol, 206, 2049, 10.1242/jeb.00241

Randle, 1963, The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus., Lancet, 1, 785, 10.1016/S0140-6736(63)91500-9

Maizels, 1977, Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat., Biochem J, 162, 557, 10.1042/bj1620557

Randle, 1994, Glucose fatty acid interactions and the regulation of glucose disposal, J Cell Biochem 55, Suppl, 1

Ruderman, 1999, Malonyl-CoA, fuel sensing, and insulin resistance, Am J Physiol, 276, E1

Ruderman, 2003, Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity., Endocrinology, 144, 5166, 10.1210/en.2003-0849

Silva, 2000, Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes., Nat Genet, 26, 336, 10.1038/81649

Williamson, 1980, Regulation of the citric acid cycle in mammalian systems, FEBS Lett 117, Suppl, K73, 10.1016/0014-5793(80)80572-2

Rustin, 1997, Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human., Biochim Biophys Acta, 1361, 185, 10.1016/S0925-4439(97)00035-5

Sugden, 2002, Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia., Curr Drug Targets Immune Endocr Metabol Disord, 2, 151, 10.2174/1568005310202020151

Huang, 2002, Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-α ligands, glucocorticoids, and insulin., Diabetes, 51, 276, 10.2337/diabetes.51.2.276

Astuti, 2001, Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma., Am J Hum Genet, 69, 49, 10.1086/321282

Tomlinson, 2002, Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer., Nat Genet, 30, 406, 10.1038/ng849

Duke, 1999, Dysoxia and lactate., Arch Dis Child, 81, 343, 10.1136/adc.81.4.343

McLane, 1979, Glycogen synthesis from lactate in the three types of skeletal muscle., J Biol Chem, 254, 6548, 10.1016/S0021-9258(18)50402-6

Barthel, 2003, Novel concepts in insulin regulation of hepatic gluconeogenesis, Am J Physiol Endocrinol Metab, 285, E685, 10.1152/ajpendo.00253.2003

Del Prato, 1993, Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus., J Clin Invest, 91, 484, 10.1172/JCI116226

Revers, 1984, Influence of hyperglycemia on insulin’s in vivo effects in type II diabetes., J Clin Invest, 73, 664, 10.1172/JCI111258

Kelley, 1990, Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus., J Clin Invest, 86, 1999, 10.1172/JCI114935

Henquin, 2000, Triggering and amplifying pathways of regulation of insulin secretion by glucose., Diabetes, 49, 1751, 10.2337/diabetes.49.11.1751

Ristow, 1997, Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance., J Clin Invest, 100, 2833, 10.1172/JCI119831

Mandarino, 1990, Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus., J Clin Endocrinol Metab, 71, 1544, 10.1210/jcem-71-6-1544

Majer, 1998, Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects., Mol Genet Metab, 65, 181, 10.1006/mgme.1998.2748

Gerbitz, 1996, Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit., Diabetes, 45, 113, 10.2337/diab.45.2.113

Velho, 1996, Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation., Diabetes, 45, 478, 10.2337/diab.45.4.478

Kadowaki, 1994, A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA., N Engl J Med, 330, 962, 10.1056/NEJM199404073301403

Lee, 1998, Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus., Diabetes Res Clin Pract, 42, 161, 10.1016/S0168-8227(98)00110-7

Kelley, 2002, Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes., Diabetes, 51, 2944, 10.2337/diabetes.51.10.2944

Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance., Science, 300, 1140, 10.1126/science.1082889

Yang, 2002, Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians., Diabetologia, 45, 1584, 10.1007/s00125-002-0905-7

Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1., Proc Natl Acad Sci USA, 100, 8466, 10.1073/pnas.1032913100

Mootha, 2003, PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes., Nat Genet, 34, 267, 10.1038/ng1180

Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis., Cell, 92, 829, 10.1016/S0092-8674(00)81410-5

Puigserver, 2003, Peroxisome proliferator-activated receptor-γ coactivator 1 α (PGC-1 α): transcriptional coactivator and metabolic regulator., Endocr Rev, 24, 78, 10.1210/er.2002-0012

Stone, 2002, A major predisposition locus for severe obesity, at 4p15–p14., Am J Hum Genet, 70, 1459, 10.1086/340670

Ek, 2001, Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus., Diabetologia, 44, 2220, 10.1007/s001250100032

Lacquemant, 2002, No association between the G482S polymorphism of the proliferator-activated receptor-γ coactivator-1 (PGC-1) gene and type II diabetes in French Caucasias., Diabetologia, 45, 602, 10.1007/s00125-002-0783-z

Sirover, 1997, Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology., J Cell Biochem, 66, 133, 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.0.CO;2-R

Du, 2003, Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells., J Clin Invest, 112, 1049, 10.1172/JCI18127

Gastaldelli, 2001, Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients., Diabetes, 50, 1807, 10.2337/diabetes.50.8.1807

Yoshiuchi, 1998, Mutation/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients., J Clin Endocrinol Metab, 83, 1016

Bergman, 2000, Free fatty acids and pathogenesis of type 2 diabetes mellitus., Trends Endocrinol Metab, 11, 351, 10.1016/S1043-2760(00)00323-4

Shah, 2002, Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans., Diabetes, 51, 301, 10.2337/diabetes.51.2.301

Hundal, 2000, Mechanism by which metformin reduces glucose production in type 2 diabetes., Diabetes, 49, 2063, 10.2337/diabetes.49.12.2063

Stumvoll, 1995, Metabolic effects of metformin in non-insulin-dependent diabetes mellitus., N Engl J Med, 333, 550, 10.1056/NEJM199508313330903

Radziuk, 1997, Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver., Diabetes, 46, 1406, 10.2337/diab.46.9.1406

Argaud, 1993, Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes., Eur J Biochem, 213, 1341, 10.1111/j.1432-1033.1993.tb17886.x

Large, 1999, Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin., Diabetes, 48, 1251, 10.2337/diabetes.48.6.1251

Musi, 2002, Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes., Diabetes, 51, 2074, 10.2337/diabetes.51.7.2074

Fujiwara, 1995, Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL/KsJ-db/db mice., Metabolism, 44, 486, 10.1016/0026-0495(95)90056-X

Raman, 2000, Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis., Eur J Pharmacol, 409, 19, 10.1016/S0014-2999(00)00806-2

da Tos, 2000, Mechanisms of acute and chronic hypoglycemic action of gliclazide., Acta Diabetol, 37, 201, 10.1007/s005920070006

Del Prato, 1991, Hepatic sensitivity to insulin: effects of sulfonylurea drugs., Am J Med, 90, 29, 10.1016/0002-9343(91)90415-T

Riccio, 1996, Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients., Metabolism, 45, 1196, 10.1016/S0026-0495(96)90235-8

Lechuga, 2001, Decreased responsiveness of gluconeogenesis to the modulation by sulfonylureas in hepatocytes isolated from obese (fa/fa) Zucker rats., Life Sci, 68, 1617, 10.1016/S0024-3205(01)00965-1

Ohlson, 1988, Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913., Diabetologia, 31, 798, 10.1007/BF00277480

Sandqvist, 2001, Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes., Diabetes, 50, 2344, 10.2337/diabetes.50.10.2344

Avogaro, 1996, Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals., J Clin Invest, 98, 108, 10.1172/JCI118754

DiGirolamo, 1992, Lactate production in adipose tissue: a regulated function with extra-adipose implications., FASEB J, 6, 2405, 10.1096/fasebj.6.7.1563593

Vettor, 1997, Lactate infusion in anesthetized rats produces insulin resistance in heart and skeletal muscles., Metabolism, 46, 684, 10.1016/S0026-0495(97)90014-7

Ferrannini, 1993, Metabolic and thermogenic effects of lactate infusion in humans, Am J Physiol, 265, E504

Paquot, 1995, Effects of infused sodium lactate on glucose and energy metabolism in healthy humans., Diabete Metab, 21, 345

Consoli, 1990, Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism., J Clin Invest, 86, 2038, 10.1172/JCI114940

Roef, 2003, Gluconeogenesis in humans with induced hyperlactatemia during low-intensity exercise, Am J Physiol Endocrinol Metab, 284, E1162, 10.1152/ajpendo.00425.2002

Miller, 2002, Lactate and glucose interactions during rest and exercise in men: effect of exogenous lactate infusion., J Physiol, 544, 963, 10.1113/jphysiol.2002.027128

Stellingwerff, 2003, Effects of reduced free fatty acid availability on skeletal muscle PDH activation during aerobic exercise, Pyruvate dehydrogenase. Am J Physiol Endocrinol Metab, 284, E589, 10.1152/ajpendo.00418.2002

DeFronzo, 1981, The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization., Diabetes, 30, 1000, 10.2337/diab.30.12.1000

Baron, 1988, Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans, Am J Physiol, 255, E769

Gloria-Bottini, 2001, Phosphoglucomutase genetic polymorphism of newborns., Am J Hum Biol, 13, 9, 10.1002/1520-6300(200101/02)13:1<9::AID-AJHB1001>3.0.CO;2-1

Roach, 1990, Control of glycogen synthase by hierarchal protein phosphorylation., FASEB J, 4, 2961, 10.1096/fasebj.4.12.2168324

Lawrence Jr, 1997, New insights into the role and mechanism of glycogen synthase activation by insulin., Diabetes, 46, 541, 10.2337/diab.46.4.541

Alonso, 1995, A new look at the biogenesis of glycogen., FASEB J, 9, 1126, 10.1096/fasebj.9.12.7672505

Manchester, 1996, Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle., Proc Natl Acad Sci USA, 93, 10707, 10.1073/pnas.93.20.10707

Orho, 1998, Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0., J Clin Invest, 102, 507, 10.1172/JCI2890

Halse, 2003, Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase., Diabetes, 52, 9, 10.2337/diabetes.52.1.9

Shulman, 1995, In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis., Proc Natl Acad Sci USA, 92, 8535, 10.1073/pnas.92.19.8535

Fernandez-Novell, 1996, Translocation and aggregation of hepatic glycogen synthase during the fasted-to-refed transition in rats., Eur J Biochem, 238, 570, 10.1111/j.1432-1033.1996.0570z.x

Ferrer, 1997, Muscle glycogen synthase translocates from the cell nucleus to the cystosol in response to glucose., FEBS Lett, 415, 249, 10.1016/S0014-5793(97)01136-8

Dent, 1990, The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle., Nature, 348, 302, 10.1038/348302a0

Haystead, 1989, Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism., Nature, 337, 78, 10.1038/337078a0

Cohen, 2002, Protein phosphatase 1–targeted in many directions., J Cell Sci, 115, 241, 10.1242/jcs.115.2.241

Delibegovic, 2003, Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance., Diabetes, 52, 596, 10.2337/diabetes.52.3.596

Cross, 1995, Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B., Nature, 378, 785, 10.1038/378785a0

Fang, 2002, Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway., Mol Cell Biol, 22, 2099, 10.1128/MCB.22.7.2099-2110.2002

Pap, 2002, Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β signaling pathway., Mol Cell Biol, 22, 578, 10.1128/MCB.22.2.578-586.2002

Jia, 2002, Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus., Nature, 416, 548, 10.1038/nature733

Hoeflich, 2000, Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation., Nature, 406, 86, 10.1038/35017574

Bruno, 1999, A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy., Neuromuscul Disord, 9, 403, 10.1016/S0960-8966(99)00040-1

Mu, 1998, Characterization of human glycogenin-2, a self-glucosylating initiator of liver glycogen metabolism., J Biol Chem, 273, 34850, 10.1074/jbc.273.52.34850

Lin, 1999, Self-glucosylation of glycogenin, the initiator of glycogen biosynthesis, involves an inter-subunit reaction., Arch Biochem Biophys, 363, 163, 10.1006/abbi.1998.1073

Pitcher, 1988, Glycogenin is the priming glucosyltransferase required for the initiation of glycogen biogenesis in rabbit skeletal muscle., Eur J Biochem, 176, 391, 10.1111/j.1432-1033.1988.tb14294.x

Baque, 1997, Glycogenin, the primer of glycogen synthesis, binds to actin., FEBS Lett, 417, 355, 10.1016/S0014-5793(97)01299-4

Skurat, 2002, GNIP, a novel protein that binds and activates glycogenin, the self-glucosylating initiator of glycogen biosynthesis., J Biol Chem, 277, 19331, 10.1074/jbc.M201190200

Biorn, 2001, The amino-terminal tail of glycogen phosphorylase is a switch for controlling phosphorylase conformation, activation, and response to ligands., Biochemistry, 40, 5181, 10.1021/bi0020372

Hendrickx, 1996, Genetic deficiencies of the glycogen phosphorylase system., Hum Genet, 97, 551, 10.1007/BF02281858

Wolfsdorf, 2003, Glycogen storage diseases., Rev Endocr Metab Disord, 4, 95, 10.1023/A:1021831621210

Burwinkel, 1998, Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI., Am J Hum Genet, 62, 785, 10.1086/301790

Shaiu, 2000, Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease., Mol Genet Metab, 69, 16, 10.1006/mgme.1999.2953

Pratipanawatr, 2002, Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes., Diabetes, 51, 462, 10.2337/diabetes.51.2.462

Fery, 1994, Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM., Diabetes, 43, 1418, 10.2337/diab.43.12.1418

Huang, 2000, Impaired insulin-stimulated expression of the glycogen synthase gene in skeletal muscle of type 2 diabetic patients is acquired rather than inherited., J Clin Endocrinol Metab, 85, 1584

Schalin-Jantti, 1992, Impaired activation of glycogen synthase in people at increased risk for developing NIDDM., Diabetes, 41, 598, 10.2337/diab.41.5.598

Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus., J Clin Invest, 89, 782, 10.1172/JCI115656

Kida, 1990, Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle., J Clin Invest, 85, 476, 10.1172/JCI114462

Groop, 1993, Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus., N Engl J Med, 328, 10, 10.1056/NEJM199301073280102

Zhang, 1996, UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and β 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study., Diabetologia, 39, 1505, 10.1007/s001250050605

Rissanen, 1997, New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland., Diabetologia, 40, 1313, 10.1007/s001250050826

Cusi, 1996, Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus., J Clin Endocrinol Metab, 81, 4059

Hardie, 2003, Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status., Endocrinology, 144, 5179, 10.1210/en.2003-0982

Mojena, 1989, Effect of sulfonylureas on hepatic glycogen metabolism: activation of glycogen phosphorylase., Metabolism, 38, 466, 10.1016/0026-0495(89)90200-X

Nikoulina, 2000, Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes., Diabetes, 49, 263, 10.2337/diabetes.49.2.263

Hansen, 1997, Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and β isoforms in patients with NIDDM., Diabetologia, 40, 940, 10.1007/s001250050771

Nikoulina, 2002, Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle., Diabetes, 51, 2190, 10.2337/diabetes.51.7.2190

Morral, 2003, Novel targets and therapeutic strategies for type 2 diabetes., Trends Endocrinol Metab, 14, 169, 10.1016/S1043-2760(03)00031-6

Ring, 2003, Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo., Diabetes, 52, 588, 10.2337/diabetes.52.3.588

Hansen, 1995, A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin., Hum Mol Genet, 4, 1313, 10.1093/hmg/4.8.1313

Xia, 1998, A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes., Diabetes, 47, 1519, 10.2337/diabetes.47.9.1519

Maegawa, 1999, The 3′-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population., Diabetes, 48, 1469, 10.2337/diabetes.48.7.1469

Savage, 2002, Digenic inheritance of severe insulin resistance in a human pedigree., Nat Genet, 31, 379, 10.1038/ng926

Hegele, 1998, Variation in the AU(AT)-rich element within the 3′-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians., J Clin Endocrinol Metab, 83, 3980

Shen, 1998, Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM., Diabetes Care, 21, 1086, 10.2337/diacare.21.7.1086

Hansen, 2000, Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity., Diabetes, 49, 298, 10.2337/diabetes.49.2.298

Shah, 2000, Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus., J Clin Endocrinol Metab, 85, 4053

Christiansen, 2000, Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes., Diabetes, 49, 1691, 10.2337/diabetes.49.10.1691

Martin, 1998, Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo., Proc Natl Acad Sci USA, 95, 1776, 10.1073/pnas.95.4.1776

Aiston, 2001, Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis., J Biol Chem, 276, 23858, 10.1074/jbc.M101454200

West, 2000, Radicals and oxidative stress in diabetes., Diabet Med, 17, 171, 10.1046/j.1464-5491.2000.00259.x

Vulliamy, 1988, Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia., Proc Natl Acad Sci USA, 85, 5171, 10.1073/pnas.85.14.5171

Kugler, 1998, Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency., Hum Genet, 103, 450, 10.1007/s004390050849

Marshall, 1991, Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance., J Biol Chem, 266, 4706, 10.1016/S0021-9258(19)67706-9

Milewski, 2002, Glucosamine-6-phosphate synthase–the multi-facets enzyme., Biochim Biophys Acta, 1597, 173, 10.1016/S0167-4838(02)00318-7

Wells, 2001, Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc., Science, 291, 2376, 10.1126/science.1058714

McClain, 1996, Hexosamines and insulin resistance., Diabetes, 45, 1003, 10.2337/diab.45.8.1003

Traxinger, 1991, Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation., J Biol Chem, 266, 10148, 10.1016/S0021-9258(18)99202-1

Wang, 1998, A nutrient-sensing pathway regulates leptin gene expression in muscle and fat., Nature, 393, 684, 10.1038/31474

Obici, 2002, Identification of a biochemical link between energy intake and energy expenditure., J Clin Invest, 109, 1599, 10.1172/JCI0215258

Baron, 1995, Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity., J Clin Invest, 96, 2792, 10.1172/JCI118349

Hawkins, 1999, Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity., J Biol Chem, 274, 31312, 10.1074/jbc.274.44.31312

Robinson, 1993, Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor., Diabetes, 42, 1333, 10.2337/diab.42.9.1333

Crook, 1995, Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase., Diabetes, 44, 314, 10.2337/diab.44.3.314

Crook, 2000, Overexpression of glutamine:fructose-6-phosphate amidotransferase in rat-1 fibroblasts enhances glucose-mediated glycogen accumulation via suppression of glycogen phosphorylase activity., Endocrinology, 141, 1962, 10.1210/endo.141.6.7483

Barzilai, 1996, Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production., Diabetes, 45, 1329, 10.2337/diab.45.10.1329

Balkan, 1994, Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats., Diabetes, 43, 1173, 10.2337/diab.43.10.1173

Traxinger, 1992, Insulin regulation of pyruvate kinase activity in isolated adipocytes. Crucial role of glucose and the hexosamine biosynthesis pathway in the expression of insulin action., J Biol Chem, 267, 9718, 10.1016/S0021-9258(19)50150-8

Hawkins, 1997, Role of the glucosamine pathway in fat-induced insulin resistance., J Clin Invest, 99, 2173, 10.1172/JCI119390

Hebert Jr, 1996, Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance., J Clin Invest, 98, 930, 10.1172/JCI118876

Tang, 2000, Transgenic mice with increased hexosamine flux specifically targeted to β-cells exhibit hyperinsulinemia and peripheral insulin resistance., Diabetes, 49, 1492, 10.2337/diabetes.49.9.1492

Yki-Jarvinen, 1996, Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM., Diabetes, 45, 302, 10.2337/diab.45.3.302

Daniels, 1996, Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin., J Clin Invest, 97, 1235, 10.1172/JCI118538

Considine, 2000, Hexosamines regulate leptin production in human subcutaneous adipocytes., J Clin Endocrinol Metab, 85, 3551

Monauni, 2000, Effects of glucosamine infusion on insulin secretion and insulin action in humans., Diabetes, 49, 926, 10.2337/diabetes.49.6.926

Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications., Nature, 414, 813, 10.1038/414813a

Du, 2001, Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site., J Clin Invest, 108, 1341, 10.1172/JCI11235

Goldberg, 2000, Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells., Diabetes, 49, 863, 10.2337/diabetes.49.5.863

Singh, 2001, Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C., Diabetes, 50, 2355, 10.2337/diabetes.50.10.2355

Federici, 2002, Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells., Circulation, 106, 466, 10.1161/01.CIR.0000023043.02648.51

Du, 2000, Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation., Proc Natl Acad Sci USA, 97, 12222, 10.1073/pnas.97.22.12222

Nerlich, 1998, Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes., Diabetes, 47, 170, 10.2337/diab.47.2.170